Skip to main content
NCBI home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2007 Aug 26;21:S30–S33. doi: 10.1016/S0268-960X(07)70009-7

I08 Development of transfusion medicine in Europe A challenge for physicians, scientists and politicians

E Seifried a,b,*, MM Mueller a,**
PMCID: PMC7130959

The content is available as a PDF (128.5 KB).

Reference(s)

  • 1.Roth WK, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in an blood-bank setting. Lancet. 1999;353:359–363. doi: 10.1016/S0140-6736(98)06318-1. [DOI] [PubMed] [Google Scholar]
  • 2.Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet. 2003;361:161–169. doi: 10.1016/S0140-6736(03)12195-2. [DOI] [PubMed] [Google Scholar]
  • 3.Llewelyn CA, Hewitt PE, Knight RSG. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet. 2004;363:417–421. doi: 10.1016/S0140-6736(04)15486-X. [DOI] [PubMed] [Google Scholar]
  • 4.Aguzzi A, Glatzel M. vCJD tissue distribution and transmission by transfusion a worst-case scenario coming true? Lancet. 2004;363:411–412. doi: 10.1016/S0140-6736(04)15520-7. [DOI] [PubMed] [Google Scholar]
  • 5.Schmidt M, Brixner V, Ruester B. NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion. 2004;44:470–475. doi: 10.1111/j.1537-2995.2004.03269.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Assmus B, Honold J, Schaechinger V. Transcoronary transplantation of progenitor cells in patients with persistent left ventricular dysfunction after myocardial infarction: a randomized controlled trial (TOPCARE-CHD) N Engl J Med. 2006;355:1222–1232. doi: 10.1056/NEJMoa051779. [DOI] [PubMed] [Google Scholar]
  • 7.Schaechinger V, Erbs S, Elsasser A. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210–1221. doi: 10.1056/NEJMoa060186. [DOI] [PubMed] [Google Scholar]
  • 8.Woolhouse MEJ. Population biology of emerging and re-emerging pathogens. Trends Microbiol. 2002;10:S3–S7. doi: 10.1016/s0966-842x(02)02428-9. [DOI] [PubMed] [Google Scholar]
  • 9.Seifried E, Mueller MM. European Parliamentary Public Hearing on ‘The Impact of SARS and Other Emerging Pathogens on Transfusion Medicine’. Blood Therapies in Medicine. 2003;3:109–110. [Google Scholar]

Articles from Blood Reviews are provided here courtesy of Elsevier

RESOURCES